UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022723
Receipt number R000025937
Scientific Title An analysis on usefulness of monitoring by wristwatch-type sphygmograph in evaluation of recurrence of atrial fibrillation after catheter ablation (CVI ARO 3b study)
Date of disclosure of the study information 2016/06/13
Last modified on 2020/12/16 10:41:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An analysis on usefulness of monitoring by wristwatch-type sphygmograph in evaluation of recurrence of atrial fibrillation after catheter ablation (CVI ARO 3b study)

Acronym

CVI ARO 3b study

Scientific Title

An analysis on usefulness of monitoring by wristwatch-type sphygmograph in evaluation of recurrence of atrial fibrillation after catheter ablation (CVI ARO 3b study)

Scientific Title:Acronym

CVI ARO 3b study

Region

Japan


Condition

Condition

Atrial fibrillation after catheter ablation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the accuracy of wristwatch-type sphygmograph in detection of recurrence of atrial fibrillation after catheter ablation in comparison to 24h ambulatory electrocardiogram, and to evaluate the difference between 72h and 24h monitoring for this purpose.

Basic objectives2

Others

Basic objectives -Others

Evaluation of usefulness of sphygmographic devise

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Recurrence of atrial fibrillation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with atrial fibrillation more than 3 months after catheter ablation in the Cardiovascular Institute, who can visit for the second successive day for 24h ambulatory electrocardiogram

Key exclusion criteria

(1) Outdwellers having the difficulty in performance of 24h ambulatory monitoring (visiting for the second successive day)
(2) Metallic allergy

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Otsuka
Middle name
Last name Takayuki

Organization

The Cardiovascular Institute

Division name

Department of cardiovascular medicine

Zip code

106-0031

Address

3-2-19 Nishiazabu, Minato-Ku, Tokyo. ZIP: 106-0031

TEL

+81-3-3408-2151

Email

otsuka@cvi.or.jp


Public contact

Name of contact person

1st name Matsuda
Middle name
Last name Kazumi

Organization

Cardiovascular Institute Academic Research Organization (CVI ARO)

Division name

Head office

Zip code

106-0031

Address

3-2-19 Nishiazabu, Minato-Ku, Tokyo

TEL

+81-3-3408-2151

Homepage URL


Email

matsuda@cvi.or.jp


Sponsor or person

Institute

The Cardiovascular Institute Academic Organization (CVI ARO)

Institute

Department

Personal name



Funding Source

Organization

Seiko Epson Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of The Cardiovascular Institute

Address

3-2-19 Nishiazabu, Minato-Ku, Tokyo

Tel

03-3408-2151

Email

matsuda@cvi.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

心臓血管研究所付属病院(The Cardiovascular Institute)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 13 Day


Related information

URL releasing protocol

https://www.cvi.or.jp/kenkyujo/cviaro.html

Publication of results

Published


Result

URL related to results and publications

https://www.cvi.or.jp/kenkyujo/cviaro.html

Number of participants that the trial has enrolled

199

Results

Totally, 199 patients undergoing catheter ablation for atrial fibrillation were enrolled.
Post procedural arrhythmia (PPA) was detected by holter ECG in 7 patients, while 26 patients were diagnosed as PPA by pulse-wave sensitive wrist-watch (PWSW).
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the detection of PPA with PWSW were 71.4%, 89.1%, 19.2%, 99.8%, respectively.

Results date posted

2020 Year 12 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients undergoing catheter ablation for atrial fibrillation were enrolled.

Participant flow

Data of all participants were assessed.

Adverse events

None.

Outcome measures

Post procedural arrhythmia (PPA) was detected by holter ECG in 7 patients, while 26 patients were diagnosed as PPA by pulse-wave sensitive wrist-watch (PWSW).
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the detection of PPA with PWSW were 71.4%, 89.1%, 19.2%, 99.8%, respectively.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 19 Day

Date of IRB

2016 Year 05 Month 09 Day

Anticipated trial start date

2015 Year 05 Month 15 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 09 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Investigation was completed.


Management information

Registered date

2016 Year 06 Month 13 Day

Last modified on

2020 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025937


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name